DOCGO INC
DCGONASDAQTrading Snapshot
- Day Range
- $0.17 β $0.18
- 52-Week Range
- $0.18 β $1.10
- Volume (shares)
- 1,019,347
- Avg Volume (shares)
- β
- Shares Outstanding
- 98.9M
- Next Earnings
- 2027-03-15
Fundamentals Snapshot
- Annual Revenue
- $322M
- Last Q Revenue
- $73M
- P/E Ratio
- β
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-1.85
- Dividend Yield
- β
- Dilution (1yr)
- β3.8%
DOCGO INC
DCGOAbout DOCGO INC
DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates

DocGo Inc. (DCGO) Q3 2026 Earnings Call Transcript
DocGo Inc. (DCGO) Q3 2026 Earnings Call Transcript

DocGo Inc. (DCGO) Reports Q3 Loss, Lags Revenue Estimates
DocGo Inc. (DCGO) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.11 per share a year ago.

DocGo Announces Third Quarter 2026 Results and CEO Transition
NEW YORK--(BUSINESS WIRE)--DocGo Announces Q3 2026 Results and CEO Transition. Gross Margin Improves 280 Basis Points Over Q2 Due to Company Profitability Initiatives.

DocGo to Announce Third Quarter 2026 Results on Monday, November 9, 2026
NEW YORK--(BUSINESS WIRE)--DocGo to Announce Third Quarter 2026 Results on Monday, November 9, 2026. Management to host conference call and webcast at 5:00 p.m. ET on that day.

DocGo Inc. (NASDAQ:DCGO) Stock Has Average Target Price of $2.38
DocGo Inc. (NASDAQ: DCGO - Get Free Report) has received an average recommendation of "Hold" from the six ratings firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a se

Lumexa Imaging (NASDAQ:LMRI) versus DocGo (NASDAQ:DCGO) Head-To-Head Comparison
Lumexa Imaging (NASDAQ: LMRI - Get Free Report) and DocGo (NASDAQ: DCGO - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strengt